On the public citation graph
Targeting Conformational Plasticity of Protein Kinases
0 signed · 215 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/anie.200502770openalex-snapshot
NMR Characterization of Kinase p38 Dynamics in Free and Ligand‐Bound Forms
inferredcites →https://doi.org/10.1002/cbic.201200316openalex-snapshot
A Novel Approach to the Discovery of Small‐Molecule Ligands of CDK2
inferredcites →https://doi.org/10.1016/j.bmcl.2004.11.011openalex-snapshot
Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors
inferredcites →https://doi.org/10.1016/j.bmcl.2007.11.015openalex-snapshot
Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity
inferredcites →https://doi.org/10.1016/j.bmcl.2008.10.054openalex-snapshot
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901
inferredcites →https://doi.org/10.1016/j.ccr.2006.12.017openalex-snapshot
Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity
inferredcites →https://doi.org/10.1016/j.cell.2007.10.057openalex-snapshot
Structure of the Dual Enzyme Ire1 Reveals the Basis for Catalysis and Regulation in Nonconventional RNA Splicing
inferredcites →https://doi.org/10.1016/j.cell.2014.07.002openalex-snapshot
Allosteric Inhibition of the IRE1α RNase Preserves Cell Viability and Function during Endoplasmic Reticulum Stress
inferredcites →https://doi.org/10.1016/j.celrep.2013.06.025openalex-snapshot
Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations
inferredcites →https://doi.org/10.1016/j.chembiol.2012.12.006openalex-snapshot
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
inferredcites →https://doi.org/10.1016/j.chembiol.2013.05.005openalex-snapshot
Sequence Determinants of a Specific Inactive Protein Kinase Conformation
inferredcites →https://doi.org/10.1016/j.chembiol.2014.02.016openalex-snapshot
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases
inferredcites →https://doi.org/10.1016/j.chembiol.2014.05.005openalex-snapshot
Modulating Noncatalytic Function with Kinase Inhibitors
inferredcites →https://doi.org/10.1016/j.coph.2010.09.002openalex-snapshot
Allostery and population shift in drug discovery
inferredcites →https://doi.org/10.1016/j.coph.2014.07.015openalex-snapshot
Recently targeted kinases and their inhibitors—the path to clinical trials
inferredcites →https://doi.org/10.1016/j.jmb.2014.02.011openalex-snapshot
Extracellular-Regulated Kinase 2 Is Activated by the Enhancement of Hinge Flexibility
inferredcites →https://doi.org/10.1016/j.lungcan.2005.10.006openalex-snapshot
EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib
inferredcites →https://doi.org/10.1016/j.str.2007.01.015openalex-snapshot
c-Src Binds to the Cancer Drug Imatinib with an Inactive Abl/c-Kit Conformation and a Distributed Thermodynamic Penalty
inferredcites →https://doi.org/10.1016/j.str.2007.12.016openalex-snapshot
Mechanism of Activation and Inhibition of the HER4/ErbB4 Kinase
inferredcites →https://doi.org/10.1016/j.str.2009.02.010openalex-snapshot
Binding of Small-Molecule Ligands to Proteins: “What You See” Is Not Always “What You Get”
inferredcites →https://doi.org/10.1016/j.str.2012.11.014openalex-snapshot
Insights into the Aberrant Activity of Mutant EGFR Kinase Domain and Drug Recognition
inferredcites →https://doi.org/10.1016/s0092-8674(02)00741-9openalex-snapshot
The Conformational Plasticity of Protein Kinases
inferredcites →https://doi.org/10.1016/s0960-894x(03)00656-5openalex-snapshot
The kinetics of binding to p38 MAP kinase by analogues of BIRB 796
inferredcites →https://doi.org/10.1021/bi100070ropenalex-snapshot
Analysis of Imatinib and Sorafenib Binding to p38α Compared with c-Abl and b-Raf Provides Structural Insights for Understanding the Selectivity of Inhibitors Targeting the DFG-Out Form of Protein Kinases
inferredcites →https://doi.org/10.1021/cb100410mopenalex-snapshot
Discovery of a Potential Allosteric Ligand Binding Site in CDK2
inferredcites →https://doi.org/10.1021/cb300663jopenalex-snapshot
Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features
inferredcites →https://doi.org/10.1021/cb400663kopenalex-snapshot
Conformation-Selective Inhibitors Reveal Differences in the Activation and Phosphate-Binding Loops of the Tyrosine Kinases Abl and Src
inferredcites →https://doi.org/10.1021/cb500129topenalex-snapshot
Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?
inferredcites →https://doi.org/10.1021/cb500355copenalex-snapshot
Discovery of Inter-Domain Stabilizers—A Novel Assay System for Allosteric Akt Inhibitors
inferredcites →https://doi.org/10.1021/cr000230wopenalex-snapshot
Kinetic and Catalytic Mechanisms of Protein Kinases
inferredcites →https://doi.org/10.1021/ja104903xopenalex-snapshot
In Vitro Selection of a DNA-Templated Small-Molecule Library Reveals a Class of Macrocyclic Kinase Inhibitors
inferredcites →https://doi.org/10.1021/ja202726yopenalex-snapshot
How Does a Drug Molecule Find Its Target Binding Site?
inferredcites →https://doi.org/10.1021/ja303858wopenalex-snapshot
Direct Binding Assay for the Detection of Type IV Allosteric Inhibitors of Abl
inferredcites →https://doi.org/10.1021/ja405939xopenalex-snapshot
Computational Analysis of the Binding Specificity of Gleevec to Abl, c-Kit, Lck, and c-Src Tyrosine Kinases
inferredcites →https://doi.org/10.1021/ja902010popenalex-snapshot
Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors
inferredcites →https://doi.org/10.1021/ja907795qopenalex-snapshot
High-Throughput Screening To Identify Inhibitors Which Stabilize Inactive Kinase Conformations in p38α
inferredcites →https://doi.org/10.1021/jm901443hopenalex-snapshot
Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation
inferredcites →https://doi.org/10.1038/385595a0openalex-snapshot
Three-dimensional structure of the tyrosine kinase c-Src
inferredcites →https://doi.org/10.1038/emboj.2011.18openalex-snapshot
Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response
inferredcites →https://doi.org/10.1038/nature07661openalex-snapshot
The unfolded protein response signals through high-order assembly of Ire1
inferredcites →https://doi.org/10.1038/nature08675openalex-snapshot
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
inferredcites →https://doi.org/10.1038/nbt.1990openalex-snapshot
Comprehensive analysis of kinase inhibitor selectivity
inferredcites →https://doi.org/10.1038/nbt.2017openalex-snapshot
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
inferredcites →https://doi.org/10.1038/nchembio.1094openalex-snapshot
Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitors
inferredcites →https://doi.org/10.1038/nchembio.162openalex-snapshot
A new screening assay for allosteric inhibitors of cSrc
inferredcites →https://doi.org/10.1038/nchembio.1629openalex-snapshot
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
inferredcites →https://doi.org/10.1038/nchembio.1664openalex-snapshot
Druggable sensors of the unfolded protein response
inferredcites →https://doi.org/10.1038/nchembio.452openalex-snapshot
Dynamics connect substrate recognition to catalysis in protein kinase A
inferredcites →https://doi.org/10.1038/nchembio.792openalex-snapshot
Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles
inferredcites →https://doi.org/10.1038/nchembio799openalex-snapshot
Rational design of inhibitors that bind to inactive kinase conformations
inferredcites →https://doi.org/10.1038/ncomms4397openalex-snapshot
Activation pathway of Src kinase reveals intermediate states as targets for drug design
inferredcites →https://doi.org/10.1038/ncomms6939openalex-snapshot
A dynamically coupled allosteric network underlies binding cooperativity in Src kinase
inferredcites →https://doi.org/10.1038/nrc2559openalex-snapshot
Targeting cancer with small molecule kinase inhibitors
inferredcites →https://doi.org/10.1038/nrd2082openalex-snapshot
Drug–target residence time and its implications for lead optimization
inferredcites →https://doi.org/10.1038/nrd2130openalex-snapshot
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
inferredcites →https://doi.org/10.1038/nrd839openalex-snapshot
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
inferredcites →https://doi.org/10.1038/nsb770openalex-snapshot
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
inferredcites →https://doi.org/10.1038/nsmb.1486openalex-snapshot
Activation of tyrosine kinases by mutation of the gatekeeper threonine
inferredcites →https://doi.org/10.1038/nsmb.2849openalex-snapshot
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase
inferredcites →https://doi.org/10.1038/nsmb859openalex-snapshot
Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition
inferredcites →https://doi.org/10.1039/b710505copenalex-snapshot
Second-harmonic generation for studying structural motion of biological molecules in real time and space
inferredcites →https://doi.org/10.1039/c2md00270aopenalex-snapshot
Investigation of the effect of molecular properties on the binding kinetics of a ligand to its biological target
inferredcites →https://doi.org/10.1042/bj20041140openalex-snapshot
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
inferredcites →https://doi.org/10.1063/1.2218846openalex-snapshot
Detection of protein conformational change by optical second-harmonic generation
inferredcites →https://doi.org/10.1073/pnas.0607656103openalex-snapshot
Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism
inferredcites →https://doi.org/10.1073/pnas.0807988105openalex-snapshot
A helix scaffold for the assembly of active protein kinases
inferredcites →https://doi.org/10.1073/pnas.0811223106openalex-snapshot
A conserved protonation-dependent switch controls drug binding in the Abl kinase
inferredcites →https://doi.org/10.1073/pnas.0914782107openalex-snapshot
Probing myosin structural conformation in vivo by second-harmonic generation microscopy
inferredcites →https://doi.org/10.1073/pnas.1004594107openalex-snapshot
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
inferredcites →https://doi.org/10.1073/pnas.1214330110openalex-snapshot
Explaining why Gleevec is a specific and potent inhibitor of Abl kinase
inferredcites →https://doi.org/10.1073/pnas.1221231110openalex-snapshot
Solvent fluctuations in hydrophobic cavity–ligand binding kinetics
inferredcites →https://doi.org/10.1073/pnas.1305378110openalex-snapshot
Structure–kinetic relationship study of CDK8/CycC specific compounds
inferredcites →https://doi.org/10.1073/pnas.1314712110openalex-snapshot
NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors
inferredcites →https://doi.org/10.1073/pnas.1318899111openalex-snapshot
Phosphorylation releases constraints to domain motion in ERK2
inferredcites →https://doi.org/10.1074/jbc.m109.041590openalex-snapshot
A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
inferredcites →https://doi.org/10.1074/jbc.m109.061820openalex-snapshot
Global Consequences of Activation Loop Phosphorylation on Protein Kinase A
inferredcites →https://doi.org/10.1074/jbc.m110.109660openalex-snapshot
Molecular Dynamics Simulations Show That Conformational Selection Governs the Binding Preferences of Imatinib for Several Tyrosine Kinases
inferredcites →https://doi.org/10.1074/jbc.m111.335091openalex-snapshot
Structural Basis for the Regulation of Protein Kinase A by Activation Loop Phosphorylation
inferredcites →https://doi.org/10.1074/jbc.m207135200openalex-snapshot
Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor
inferredcites →https://doi.org/10.1074/jbc.m801337200openalex-snapshot
Solution Conformations and Dynamics of ABL Kinase-Inhibitor Complexes Determined by NMR Substantiate the Different Binding Modes of Imatinib/Nilotinib and Dasatinib
inferredcites →https://doi.org/10.1111/j.1476-5381.2010.01127.xopenalex-snapshot
Principles of early drug discovery
inferredcites →https://doi.org/10.1126/science.1075762openalex-snapshot
The Protein Kinase Complement of the Human Genome
inferredcites →https://doi.org/10.1126/science.1095920openalex-snapshot
Protein Kinase Inhibitors: Insights into Drug Design from Structure
inferredcites →https://doi.org/10.1126/science.289.5486.1938openalex-snapshot
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
inferredcites →https://doi.org/10.1126/science.3589666openalex-snapshot
Computer Simulations of the Diffusion of a Substrate to an Active Site of an Enzyme
inferredcites →https://doi.org/10.1126/scisignal.2002324openalex-snapshot
Working Without Kinase Activity: Phosphotransfer-Independent Functions of Extracellular Signal–Regulated Kinases
inferredcites →https://doi.org/10.1146/annurev-biochem-052410-090317openalex-snapshot
The Structural Basis for Control of Eukaryotic Protein Kinases
inferredcites →https://doi.org/10.1146/annurev-biochem-090308-173656openalex-snapshot
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
inferredcites →https://doi.org/10.1158/0008-5472.can-03-2868openalex-snapshot
Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase
inferredcites →https://doi.org/10.1158/0008-5472.can-04-1168openalex-snapshot
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
inferredcites →https://doi.org/10.1158/0008-5472.can-08-3953openalex-snapshot
Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-1516openalex-snapshot
Contribution of ABL Kinase Domain Mutations to Imatinib Resistance in Different Subsets of Philadelphia-Positive Patients: By the GIMEMA Working Party on Chronic Myeloid Leukemia
inferredcites →https://doi.org/10.1158/1535-7163.mct-11-1010openalex-snapshot
ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
inferredcites →https://doi.org/10.1158/2159-8290.cd-13-0070openalex-snapshot
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
inferredcites →https://doi.org/10.1177/1087057111422746openalex-snapshot
Biosensor-Based Approach to the Identification of Protein Kinase Ligands with Dual-Site Modes of Action
inferredcites →https://doi.org/10.1177/1087057113506051openalex-snapshot
Quick Evaluation of Kinase Inhibitors by Surface Plasmon Resonance Using Single-Site Specifically Biotinylated Kinases
inferredcites →https://doi.org/10.1371/journal.pbio.0040144openalex-snapshot
A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
inferredcites →https://doi.org/10.1371/journal.pone.0039713openalex-snapshot
Fluorophore Labeled Kinase Detects Ligands That Bind within the MAPK Insert of p38α Kinase
inferredcites →https://doi.org/10.4155/fmc.13.216openalex-snapshot
Novel Approaches for Targeting Kinases: Allosteric Inhibition, Allosteric Activation and Pseudokinases
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/cbic.70419openalex-snapshot
A Constellation of Fluorescent Biosensors to Illuminate the Galaxy of Protein Kinases
inferred← citeshttps://doi.org/10.1002/iub.2241openalex-snapshot
KinCon: Cell‐based recording of full‐length kinase conformations
inferred← citeshttps://doi.org/10.1002/pmic.201600235openalex-snapshot
Impact of phosphoproteomics in the translation of kinase‐targeted therapies
inferred← citeshttps://doi.org/10.1002/pro.5141openalex-snapshot
Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics
inferred← citeshttps://doi.org/10.1007/174_2022_298openalex-snapshot
Genomic Alterations in Lung Cancer
inferred← citeshttps://doi.org/10.1007/7355_2017_5openalex-snapshot
Progress in the Discovery of BCR-ABL Kinase Inhibitors for the Treatment of Leukemia
inferred← citeshttps://doi.org/10.1007/7355_2020_99openalex-snapshot
Achieving High Levels of Selectivity for Kinase Inhibitors
inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_3openalex-snapshot
Polypharmacology in Clinical Applications—Anticancer Polypharmacology
inferred← citeshttps://doi.org/10.1007/978-3-031-93894-8_9openalex-snapshot
Receptor Tyrosine Kinase Inhibitors in Combination Therapies: Integrating Chemotherapy and Radiation Therapy for Improved Cancer Treatment
inferred← citeshttps://doi.org/10.1007/978-3-319-73238-1_2openalex-snapshot
Computer-Aided Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-981-10-5187-6_5openalex-snapshot
The Story of Kinase Inhibitors Development with Special Reference to Allosteric Site
inferred← citeshttps://doi.org/10.1007/978-981-13-8719-7_3openalex-snapshot
Protein Allostery in Rational Drug Design
inferred← citeshttps://doi.org/10.1007/978-981-99-1316-9_12openalex-snapshot
CADD Approaches in Anticancer Drug Discovery
inferred← citeshttps://doi.org/10.1007/s00894-018-3849-7openalex-snapshot
Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancer
inferred← citeshttps://doi.org/10.1007/s11030-026-11696-yopenalex-snapshot
Free energy perturbation and machine learning-assisted identification of potential MAP3K8 hit molecules: a comprehensive structure- and ligand-based studies
inferred← citeshttps://doi.org/10.1007/s12013-025-01877-1openalex-snapshot
Selective Stabilization of LRRK2 Kinase Conformations Reveals Distinct Modes of Action for Type I and II Inhibitors
inferred← citeshttps://doi.org/10.1007/s12254-021-00790-6openalex-snapshot
Tracking mutation and drug-driven alterations of oncokinase conformations
inferred← citeshttps://doi.org/10.1016/b978-0-323-91287-7.00026-0openalex-snapshot
Kinase inhibitors: An overview
inferred← citeshttps://doi.org/10.1016/b978-0-443-27402-2.00010-3openalex-snapshot
Targeted protein kinase inhibitor imatinib
inferred← citeshttps://doi.org/10.1016/b978-0-443-30042-4.00003-1openalex-snapshot
Molecular thermodynamics view of biomolecular recognition, signaling, and allostery
inferred← citeshttps://doi.org/10.1016/bs.acr.2022.03.006openalex-snapshot
Cardiac complications of cancer therapies
inferred← citeshttps://doi.org/10.1016/j.bcp.2023.115973openalex-snapshot
Function and inhibition of P38 MAP kinase signaling: Targeting multiple inflammation diseases
inferred← citeshttps://doi.org/10.1016/j.chembiol.2016.07.017openalex-snapshot
Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles
inferred← citeshttps://doi.org/10.1016/j.chembiol.2020.06.014openalex-snapshot
Parallel Chemoselective Profiling for Mapping Protein Structure
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2018.12.003openalex-snapshot
Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine—(thio)urea hybrids as potential kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.01.018openalex-snapshot
An innovative kinome platform to accelerate small-molecule inhibitor discovery and optimization from hits to leads
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.01.053openalex-snapshot
Effects of rigidity on the selectivity of protein kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.06.054openalex-snapshot
Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112640openalex-snapshot
Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019)
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115475openalex-snapshot
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
inferred← citeshttps://doi.org/10.1016/j.jbc.2024.108039openalex-snapshot
Crystallographic, kinetic, and calorimetric investigation of PKA interactions with L-type calcium channels and Rad GTPase
inferred← citeshttps://doi.org/10.1016/j.jmb.2024.168871openalex-snapshot
Allosteric changes in the conformational landscape of Src kinase upon substrate binding
inferred← citeshttps://doi.org/10.1016/j.molstruc.2020.128962openalex-snapshot
Novel 2,6-disubstituted pyridine hydrazones: Synthesis, anticancer activity, docking studies and effects on caspase-3-mediated apoptosis
inferred← citeshttps://doi.org/10.1016/j.molstruc.2023.136323openalex-snapshot
Synthesis, structure characterization, DFT calculations, and computational anticancer activity investigations of 1-phenyl ethanol derivatives
inferred← citeshttps://doi.org/10.1016/j.prp.2024.155607openalex-snapshot
A review on tyrosine kinase inhibitors for targeted breast cancer therapy
inferred← citeshttps://doi.org/10.1016/j.sbi.2021.07.006openalex-snapshot
Dynamic equilibria in protein kinases
inferred← citeshttps://doi.org/10.1016/j.tips.2015.04.005openalex-snapshot
FDA-approved small-molecule kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.trsl.2022.08.004openalex-snapshot
NLRP3-mediated inflammation in cardio-oncology: sterile yet harmful
inferred← citeshttps://doi.org/10.1021/acs.biochem.5b00506openalex-snapshot
Structure-Based Assignment of Ile, Leu, and Val Methyl Groups in the Active and Inactive Forms of the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 2
inferred← citeshttps://doi.org/10.1021/acs.jafc.3c01684openalex-snapshot
Isothermal Compressibility Perturbation as a Protein Design Principle for T1 Lipase Stability–Activity Trade-Off Counteracting
inferred← citeshttps://doi.org/10.1021/acs.jctc.0c00342openalex-snapshot
Revealing the Unbinding Kinetics and Mechanism of Type I and Type II Protein Kinase Inhibitors by Local-Scaled Molecular Dynamics Simulations
inferred← citeshttps://doi.org/10.1021/acs.jctc.5b01221openalex-snapshot
Molecular Dynamics Analysis of Binding of Kinase Inhibitors to WT EGFR and the T790M Mutant
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01941openalex-snapshot
Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00073openalex-snapshot
Principles of Kinase Allosteric Inhibition and Pocket Validation
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c01629openalex-snapshot
Overcoming Secondary Mutations of Type II Kinase Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c00581openalex-snapshot
Predicting the Post-translational Modification Effects on Protein−Ligand Interactions via End-Point Binding Free Energy Calculation: Database Creation and Strategy Optimization
inferred← citeshttps://doi.org/10.1021/acs.jpcb.3c01804openalex-snapshot
Molecular Simulations of Conformational Transitions within the Insulin Receptor Kinase Reveal Consensus Features in a Multistep Activation Pathway
inferred← citeshttps://doi.org/10.1021/acs.jpcb.4c07794openalex-snapshot
Prospective Evaluation of Structure-Based Simulations Reveal Their Ability to Predict the Impact of Kinase Mutations on Inhibitor Binding
inferred← citeshttps://doi.org/10.1021/acs.jpcb.8b01530openalex-snapshot
Conformational Plasticity in Tyrosine Kinase Inhibitor–Kinase Interactions Revealed with Fluorescence Spectroscopy and Theoretical Calculations
inferred← citeshttps://doi.org/10.1021/acs.jpcb.9b00547openalex-snapshot
Phosphorylation Mechanism of N-Acetyl- l -glutamate Kinase, a QM/MM Study
inferred← citeshttps://doi.org/10.1021/acschembio.0c00429openalex-snapshot
How ATP-Competitive Inhibitors Allosterically Modulate Tyrosine Kinases That Contain a Src-like Regulatory Architecture
inferred← citeshttps://doi.org/10.1021/acschembio.5b00010openalex-snapshot
Special Issue Focused on Two Areas Pertinent to Chemical Biology: Post-Translational Modifications and New Frontiers on Kinases
inferred← citeshttps://doi.org/10.1021/acschembio.5b00940openalex-snapshot
Structural and Functional Analysis of the Allosteric Inhibition of IRE1α with ATP-Competitive Ligands
inferred← citeshttps://doi.org/10.1021/acschemneuro.1c00726openalex-snapshot
Molecular Modeling Study on the Interaction Mechanism between the LRRK2 G2019S Mutant and Type I Inhibitors by Integrating Molecular Dynamics Simulation, Binding Free Energy Calculations, and Pharmacophore Modeling
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.6b00518openalex-snapshot
Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.8b00523openalex-snapshot
Discovering New Casein Kinase 1d Inhibitors with an Innovative Molecular Dynamics Enabled Virtual Screening Workflow
inferred← citeshttps://doi.org/10.1021/acsptsci.4c00023openalex-snapshot
Ethaverine and Papaverine Target Cyclin-Dependent Kinase 5 and Inhibit Lung Cancer Cell Proliferation and Migration
inferred← citeshttps://doi.org/10.1021/jacs.9b06064openalex-snapshot
How Electrostatic Coupling Enables Conformational Plasticity in a Tyrosine Kinase
inferred← citeshttps://doi.org/10.1038/s41392-025-02129-7openalex-snapshot
Molecular principles underlying aggressive cancers
inferred← citeshttps://doi.org/10.1038/s41467-017-02240-6openalex-snapshot
Survey of solution dynamics in Src kinase reveals allosteric cross talk between the ligand binding and regulatory sites
inferred← citeshttps://doi.org/10.1038/s41467-020-15031-3openalex-snapshot
Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors
inferred← citeshttps://doi.org/10.1038/s41467-022-31215-5openalex-snapshot
Mapping the conformational energy landscape of Abl kinase using ClyA nanopore tweezers
inferred← citeshttps://doi.org/10.1038/s41467-024-45917-5openalex-snapshot
Substrate promiscuity of inositol 1,4,5-trisphosphate kinase driven by structurally-modified ligands and active site plasticity
inferred← citeshttps://doi.org/10.1038/s41589-021-00852-0openalex-snapshot
ATP-competitive partial antagonists of the IRE1α RNase segregate outputs of the UPR
inferred← citeshttps://doi.org/10.1038/s41596-025-01177-1openalex-snapshot
Detection of intramolecular protein dynamics on nanosecond-to-microsecond timescales by nanoparticle-assisted NMR spin relaxation (NASR)
inferred← citeshttps://doi.org/10.1038/s41598-019-46825-1openalex-snapshot
Molecular Modeling of ALK L1198F and/or G1202R Mutations to Determine Differential Crizotinib Sensitivity
inferred← citeshttps://doi.org/10.1038/s41598-024-57051-9openalex-snapshot
Development of a novel AAK1 inhibitor via Kinobeads-based screening
inferred← citeshttps://doi.org/10.1038/s41598-025-02175-9openalex-snapshot
Development of a small compound that regulates the function of a maltodextrin-binding protein of Streptococcus pyogenes by multifaceted screenings
inferred← citeshttps://doi.org/10.1038/s41598-025-22126-8openalex-snapshot
DeepEGFR a graph neural network for bioactivity classification of EGFR inhibitors
inferred← citeshttps://doi.org/10.1038/srep30832openalex-snapshot
Imatinib binding to human c-Src is coupled to inter-domain allostery and suggests a novel kinase inhibition strategy
inferred← citeshttps://doi.org/10.1039/9781839160745-00182openalex-snapshot
Chemical Probes for Kinases
inferred← citeshttps://doi.org/10.1039/c6cp06624kopenalex-snapshot
Energetics and structural characterization of the “DFG-flip” conformational transition of B-RAF kinase: a SITS molecular dynamics study
inferred← citeshttps://doi.org/10.1039/c9an00178fopenalex-snapshot
In situ study of RSK2 kinase activity in a single living cell by combining single molecule spectroscopy with activity-based probes
inferred← citeshttps://doi.org/10.1039/c9ra07204gopenalex-snapshot
An analogue of a kinase inhibitor exhibits subjective characteristics that contribute to its inhibitory activities as a potential anti-cancer candidate: insights through computational biomolecular modelling of UM-164 binding with lyn protein
inferred← citeshttps://doi.org/10.1042/bcj20180077openalex-snapshot
Crystal structures of the kinase domain of PpkA, a key regulatory component of T6SS, reveal a general inhibitory mechanism
inferred← citeshttps://doi.org/10.1042/bcj20230281openalex-snapshot
Activating mutations drive human MEK1 kinase using a gear-shifting mechanism
inferred← citeshttps://doi.org/10.1042/bsr20201920openalex-snapshot
Prognostic and immunological role of Fam20C in pan-cancer
inferred← citeshttps://doi.org/10.1080/07391102.2025.2475399openalex-snapshot
Activation segment of protein kinases: classification based on multidimensional analysis
inferred← citeshttps://doi.org/10.1093/bib/bbaf662openalex-snapshot
Impact of intrinsically disordered regions and functional disorder hotspots in the human kinome
inferred← citeshttps://doi.org/10.1093/plphys/kiab277openalex-snapshot
Protein kinase sensors: an overview of new designs for visualizing kinase dynamics in single plant cells
inferred← citeshttps://doi.org/10.1101/2023.08.24.554606openalex-snapshot
Off-targets of BRAF inhibitors disrupt endothelial signaling and differentially affect vascular barrier function
inferred← citeshttps://doi.org/10.1101/2024.05.23.595569openalex-snapshot
Compound Mutations in the Abl1 Kinase Cause Inhibitor Resistance by Shifting DFG Flip Mechanisms and Relative State Populations
inferred← citeshttps://doi.org/10.1101/2025.11.07.687244openalex-snapshot
Uncovering the Molecular Basis of Kinase Activity and Substrate Recognition With Phospho-PCA
inferred← citeshttps://doi.org/10.1103/prxlife.2.043019openalex-snapshot
Mpemba-Like Sensory Withdrawal Effect
inferred← citeshttps://doi.org/10.1126/sciadv.1700014openalex-snapshot
How and when does an anticancer drug leave its binding site?
inferred← citeshttps://doi.org/10.1126/sciadv.abo0696openalex-snapshot
ATP-competitive inhibitors modulate the substrate binding cooperativity of a kinase by altering its conformational entropy
inferred← citeshttps://doi.org/10.1126/science.abc2754openalex-snapshot
Conformational states dynamically populated by a kinase determine its function
inferred← citeshttps://doi.org/10.1146/annurev-cancerbio-050216-122044openalex-snapshot
Overcoming On-Target Resistance to Tyrosine Kinase Inhibitors in Lung Cancer
inferred← citeshttps://doi.org/10.1182/bloodadvances.2022007486openalex-snapshot
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML
inferred← citeshttps://doi.org/10.1371/journal.pone.0357096openalex-snapshot
Computational identification and evaluation of Adenium obesum phytochemicals as potential EGFR inhibitors for targeted therapy against non-small-cell lung cancer
inferred← citeshttps://doi.org/10.2139/ssrn.5367585openalex-snapshot
Benzimidazole-Aminopyrimidine Hybrids as Potent and Selective p38α/β MAPK Inhibitors: Design, Synthesis, Molecular Modelling Study, in vitro Enzyme Inhibition Assays, and in vivo Efficacy in Alzheimer's Model
inferred← citeshttps://doi.org/10.2174/0115680266258467231107102643openalex-snapshot
Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery
inferred← citeshttps://doi.org/10.2174/0115734099283410240406064042openalex-snapshot
Computer-aided Drug Discovery Approaches in the Identification of Anticancer Drugs from Natural Products: A Review
inferred← citeshttps://doi.org/10.2174/9789815124699123010010openalex-snapshot
Importance of In silico Tools in Anticancer Drug Discovery from Nature
inferred← citeshttps://doi.org/10.26508/lsa.202402671openalex-snapshot
Off-targets of BRAF inhibitors disrupt endothelial signaling and vascular barrier function
inferred← citeshttps://doi.org/10.3389/fphar.2020.00733openalex-snapshot
Discovering Anti-Cancer Drugs via Computational Methods
inferred← citeshttps://doi.org/10.3389/fphar.2026.1764550openalex-snapshot
Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
inferred← citeshttps://doi.org/10.3390/bioengineering9080335openalex-snapshot
Emerging Promise of Computational Techniques in Anti-Cancer Research: At a Glance
inferred← citeshttps://doi.org/10.3390/biom11040549openalex-snapshot
Conformational Plasticity-Rigidity Axis of the Coagulation Factor VII Zymogen Elucidated by Atomistic Simulations of the N-Terminally Truncated Factor VIIa Protease Domain
inferred← citeshttps://doi.org/10.3390/biophysica1020018openalex-snapshot
Modelling the Activation Pathways in Full-Length Src Kinase
inferred← citeshttps://doi.org/10.3390/cancers13092077openalex-snapshot
A Special View of What Was Almost Forgotten: p38δ MAPK
inferred← citeshttps://doi.org/10.3390/ijms22010282openalex-snapshot
The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications
inferred← citeshttps://doi.org/10.3390/ijms24119623openalex-snapshot
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study
inferred← citeshttps://doi.org/10.3390/ijms27073125openalex-snapshot
Network Pharmacology-Guided Identification of Candida albicans Secondary Metabolites as Modulators of HIV Latency via Oncogenic Signaling Pathways
inferred← citeshttps://doi.org/10.3390/molecules200915842openalex-snapshot
p38α MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening
inferred← citeshttps://doi.org/10.3390/molecules26030651openalex-snapshot
Druggable Transient Pockets in Protein Kinases
inferred← citeshttps://doi.org/10.3390/ph16040534openalex-snapshot
Structure–Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017–Present)
inferred← citeshttps://doi.org/10.3390/proteomes3040369openalex-snapshot
Fluorescent Reporters and Biosensors for Probing the Dynamic Behavior of Protein Kinases
inferred← citeshttps://doi.org/10.34184/kssb.2021.9.1.14openalex-snapshot
Structural mechanism of inhibitor-resistance by ERK2 mutations
inferred← citeshttps://doi.org/10.7554/elife.104519openalex-snapshot
Compound Mutations in the Abl1 Kinase Cause Inhibitor Resistance by Shifting DFG Flip Mechanisms and Relative State Populations
inferred← citeshttps://doi.org/10.7554/elife.104519.1openalex-snapshot
Compound Mutations in the Abl1 Kinase Cause Inhibitor Resistance by Shifting DFG Flip Mechanisms and Relative State Populations
inferred← citeshttps://doi.org/10.7554/elife.104519.2openalex-snapshot
Compound Mutations in the Abl1 Kinase Cause Inhibitor Resistance by Shifting DFG Flip Mechanisms and Relative State Populations
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.